Cardiol Therapeutics, Inc. (CRDL)
2.29
+0.07
(+3.15%)
USD |
NASDAQ |
Sep 09, 16:00
2.32
+0.03
(+1.31%)
After-Hours: 17:10
Cardiol Therapeutics Total Assets (Quarterly) : 20.69M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 20.69M |
| March 31, 2026 | 22.50M |
| December 31, 2025 | 17.23M |
| September 30, 2025 | 9.306M |
| June 30, 2025 | 14.61M |
| March 31, 2025 | 17.69M |
| December 31, 2024 | 22.16M |
| September 30, 2024 | 12.97M |
| June 30, 2024 | 19.23M |
| March 31, 2024 | 23.00M |
| December 31, 2023 | 27.83M |
| September 30, 2023 | 31.84M |
| June 30, 2023 | 35.65M |
| March 31, 2023 | 38.93M |
| December 31, 2022 | 45.78M |
| September 30, 2022 | 49.75M |
| June 30, 2022 | 57.57M |
| March 31, 2022 | 63.59M |
| Date | Value |
|---|---|
| December 31, 2021 | 69.57M |
| September 30, 2021 | 25.05M |
| June 30, 2021 | 29.68M |
| March 31, 2021 | 16.79M |
| December 31, 2020 | 12.48M |
| September 30, 2020 | 18.31M |
| June 30, 2020 | 20.13M |
| March 31, 2020 | 9.380M |
| December 31, 2019 | 11.96M |
| September 30, 2019 | 13.82M |
| June 30, 2019 | 15.71M |
| March 31, 2019 | 17.15M |
| December 31, 2018 | 18.07M |
| September 30, 2018 | 9.955M |
| June 30, 2018 | 9.232M |
| March 31, 2018 | |
| December 31, 2017 | 2.570M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 9.134M |
| NervGen Pharma Corp. | 63.57M |
| Milestone Pharmaceuticals, Inc. | 181.62M |
| Clearmind Medicine, Inc. | 14.52M |
| Lexaria Bioscience Corp. | 4.781M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.756M |
| Shareholders Equity (Quarterly) | 16.94M |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 5.553 |
| Net Debt Paydown Yield | 0.00% |